Emergent BioSolutions Canada Inc. reported 8 lobbying communications with federal officials between Sep 28, 2026 and Oct 1, 2026.
Officials contacted: Jennifer Novak (Director General) ×2; Quinn Ferris (Regional Advisor); Julie Harb (Policy Advisor); Jocelyn Milburn (Director); Harnoor Kochar (Regional Advisor); Blossom Leung (Senior Advisor).
On the agenda: To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose; Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats; Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
